These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2153401)

  • 21. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans cell-dependent antigen activation of T lymphocytes.
    Braathen LR; Thorsby E
    Scand J Immunol; 1982 Jan; 15(1):55-61. PubMed ID: 6176017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex virus antigens and inflammatory cells in oral lesions in recurrent erythema multiforme. Immunoperoxidase and autoradiographic studies.
    Malmström M; Ruokonen H; Konttinen YT; Bergroth V; Segerberg-Konttinen M; Hietanen J; Nordström D; Haapala M
    Acta Derm Venereol; 1990; 70(5):405-10. PubMed ID: 1980974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody response to herpes simplex virus type 1 polypeptides and glycoproteins in primary and recurrent infection.
    Mann DR; Hilty MD
    Pediatr Res; 1982 Mar; 16(3):176-80. PubMed ID: 6278389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex antigen in immune complexes of patients with erythema multiforme: presence following recurrent herpes simplex infection.
    Kazmierowski JA; Peizner DS; Wuepper KD
    JAMA; 1982 May; 247(18):2547-50. PubMed ID: 6279897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The proliferative T cell response to herpes simplex virus (HSV) antigen is restricted by self HLA-D.
    Berle EJ; Thorsby E
    Clin Exp Immunol; 1980 Mar; 39(3):668-75. PubMed ID: 6247109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell.
    Braun RW; Teute HK; Kirchner H; Munk K
    J Immunol; 1984 Feb; 132(2):914-9. PubMed ID: 6317753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of UV therapy on immune function in patients with psoriasis.
    Gilmour JW; Vestey JP; Norval M
    Br J Dermatol; 1993 Jul; 129(1):28-38. PubMed ID: 8396409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
    J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
    Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunology. Giving credit where credit is due.
    Serbina NV; Pamer EG
    Science; 2003 Sep; 301(5641):1856-7. PubMed ID: 14512609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of antigen presentation in the ontogeny of immune responses to herpes simplex virus.
    Howie SE; Norval M; Maingay JP; Ross JA; Neill WA
    Clin Exp Immunol; 1988 May; 72(2):201-6. PubMed ID: 2842094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of cutaneous antigen presentation in partially inbred miniature swine.
    Grabbe S; Fishbein JM; Sachs DH; Flotte TJ; Granstein RD
    Exp Dermatol; 1994 Dec; 3(6):276-82. PubMed ID: 7749572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects on murine epidermal Langerhans cells of drugs known to cause recrudescent herpes simplex virus infection in a mouse model.
    Williams NA; Hill TJ
    J Invest Dermatol; 1991 Nov; 97(5):933-7. PubMed ID: 1655914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen-presenting capacity of epidermal cells infected with vaccinia virus recombinants containing the herpes simplex virus glycoprotein D, and protective immunity.
    Wachsman M; Luo JH; Aurelian L; Perkus ME; Paoletti E
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2513-20. PubMed ID: 2550579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity.
    Sprecher E; Becker Y
    Arch Virol; 1989; 107(3-4):191-205. PubMed ID: 2554853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.